CTIS2023-505248-20-00进行中(未招募)1 期
HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- Region Skane
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+(—)
- 性别
- All
入选标准
- •To be included in the trial, the patients must meet all of the following criteria: 1)The subject has given their written consent to participate in the trial. 2)Are referred to Department of Clinical Physiology, Lund University, for suspected or known CCS or heart failure 3)Matches the inclusion criteria for sex and age (6 females and 6 males from each group in each age decade from 40 to >80 years old) 4)Matches the inclusion criteria for no known heart failure (group b) or known heart failure (group c) 5)No caffein intake <24h prior to the examination To be included in the trial, the healthy subjects must meet all of the following criteria: 1)The subject has given their written consent to participate in the trial. 2)Matches the inclusion criteria for sex and age (6 females and 6 males from each group in each age decade from 40 to >80 years old) 3)No caffein intake <24h prior to the examination
排除标准
- •Patients must not be included in this trial if any of the following criteria are met: 1)Acute referral (in-house patients) 2)Clinically unstable 3)Acute chest pain 4)Severe or decompensated heart failure 5)Non sinus rhythm (e.g. atrial fibrillation) 6)Asthma or severe chronic obstructive pulmonary disease 7)Known chronic renal failure (eGFR <30mL/min/1.73m2) 8)AV-block II or III 9)Left Bundle Branch Block 10)Systolic blood pressure <90 mmHg or >230 mmHg at rest 11)Increased intracranial pressure 12)Known allergy or adverse reaction to adenosine or mannitol 13)Known allergy or adverse reaction to gadolinium contrast agents 14)Treatment with medication containing dipyradimol or teofyllamin/teofyllin 15)Claustrophobia 16)Devices contraindicated to CMR imaging (pacemaker, implants, intracranial clips etc) 17)Pregnancy or breast feeding (screened by question only) 18)Inability to give informed consent due to mental state, language difficulties etc Healthy subjects must not be included in this trial if any of the exclusion criteria for patients are met or any of the following criteria are met: 1)Blood pressure > 140/90 measured according to clinical routine 2)Known systemic disease 3)Known cardiac disease 4)Cardiovascular medication 5)Medication that might influence cardiovascular health 6)Smoking
研究者
相似试验
进行中(未招募)
不适用
Comparison of two medicines in heartr perfusion stress studies.EUCTR2013-001225-11-FITurku University Hospital30
招募中
4 期
Hyperemic mYocardial Perfusion by adEnosine at diffeRent DosesIschemic Heart DiseaseChronic Coronary SyndromeCoronary Artery DiseaseNCT06578234Region Skane180
已完成
不适用
Hypervolemic treatment in acute non-arteriitic aioH47.0Disorders of optic nerve, not elsewhere classifiedDRKS00012603niklinik RWTH Aachen24
进行中(未招募)
不适用
Quantitative Assessment of Myocardial Perfusion with Magnetic Resonance Using an Intravascular Contrast AgentIschemic cardiomyopathy, with inducible ischemia and clinical indication to cardiac revascularizationMedDRA version: 9.1Level: LLTClassification code 10055217Term: Ischemic cardiomyopathyEUCTR2008-004895-39-GBKing's College London
已完成
不适用
Myocardial perfusion with an intravascular contrast agentCoronary artery diseaseCirculatory SystemChronic ischaemic heart diseaseISRCTN53688797King's College London (UK)156
